ArticleAdvances in therapy2025

The Real-World Impact of Glucagon-Like Peptide 1 Receptor Agonists on Asthma Control in People with High-Risk Asthma and Obesity.

Alan Kaplan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.